# Dexmedetomidine and Remifentanil in NORA

> **NCT06403670** · PHASE4 · COMPLETED · sponsor: **Baskent University Ankara Hospital** · enrollment: 76 (actual)

## Conditions studied

- Comparison of the Effects of Remifentanil and Dexmedetomidine

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT06403670
- **Lead sponsor:** Baskent University Ankara Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-17
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06403670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06403670, "Dexmedetomidine and Remifentanil in NORA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06403670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*